세계의 의료용 영상 팬텀 시장 규모 : 제품 유형별, 재료별, 최종 사용자별, 지역 범위별 및 예측

Medical Imaging Phantoms Market Size And Forecast

Medical Imaging Phantoms Market size was valued at USD 55.97 Billion in 2024 and is projected to reach USD 83.96 Billion By 2032, growing at a CAGR of 5.20% during the forecast period 2026 to 2032.

The rising disease burden of lifestyle-related disorders such as cardiac failure, chronic kidney disease, and Chronic Obstructive Pulmonary Disease (COPD) and the increasing demand for accurate calibration techniques for effective diagnostic imaging procedures are driving the growth of the Global Medical Imaging Phantoms market significantly. The Global Medical Imaging Phantoms Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Medical Imaging Phantoms Market Drivers

The market drivers for the Medical Imaging Phantoms Market can be influenced by various factors. These may include:

Growing Need for Diagnostic Imaging: The need for diagnostic imaging treatments is being driven by the increased prevalence of chronic diseases like cancer, cardiovascular disease, and neurological disorders. Medical imaging phantoms play a crucial role in the calibration and accuracy assurance of imaging systems, which in turn supports the increasing demand for accurate diagnostic instruments.

Technological Developments in Imaging Modalities: As imaging technologies such as CT, MRI, ultrasound, and nuclear medicine continue to progress, there is an increasing demand for sophisticated phantoms. Phantoms are needed in order to test novel imaging methods, improve protocols, and verify the functionality of complex imaging systems as a result of these improvements.

Growing Concern for Radiation Safety: In medical imaging, radiation safety is becoming more and more important. By facilitating precise dose estimations and streamlining imaging techniques to cut down on needless exposure, phantoms are essential for evaluating and limiting radiation exposure to patients.

Regulatory Requirements and Quality Assurance: Medical imaging equipment quality assurance must meet strict guidelines set by regulatory organisations like the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA). Phantoms are vital instruments for adhering to these rules, guaranteeing that imaging systems generate dependable and uniform outcomes.

Growing Adoption of Digital Imaging Systems: In healthcare institutions, the transition from analogue to digital imaging systems requires the usage of phantoms for validation and calibration. Phantoms are in high demand because digital imaging systems need to undergo routine quality tests to preserve image quality and diagnostic accuracy.

Global Healthcare Sector Expansion: The use of advanced medical imaging technologies is rising as a result of the global healthcare sector's expansion, especially in emerging markets. The need for imaging phantoms to guarantee the correct operation and precision of imaging equipment in recently constructed healthcare facilities is increased by this expansion.

Medical imaging phantoms: are extensively utilised for training and research reasons in research labs and educational establishments. They give researchers and students a secure setting in which to experiment and create novel imaging methods without putting patients at needless danger.

Ageing Population: As the world's population ages, the prevalence of age-related illnesses is rising, which in turn raises demand for medical imaging tests. Phantoms are essential to maintaining the precision and dependability of imaging systems that are used to identify and track these circumstances.

Customised and Patient-Specific Phantoms: The creation of customised and patient-specific phantoms has been made possible by developments in 3D printing and materials science. With the use of these phantoms, imaging systems may be tested more precisely and individually because they are designed to mimic particular anatomical features and diseases.

Partnerships and Collaborations: The development of new and enhanced phantoms is being aided by the innovative work of research centres, imaging equipment manufacturers, and healthcare providers. These collaborations are critical to the development of imaging technology and the improvement of phantom capabilities.

Global Medical Imaging Phantoms Market Restraints

Several factors can act as restraints or challenges for the Medical Imaging Phantoms Market. These may include:

Expensive Cost of Phantoms: The materials used and the level of accuracy needed during production make medical imaging phantoms costly. Smaller healthcare facilities, research institutes, and educational organisations may find it difficult to purchase and make substantial use of these phantoms because to their high cost.

Limited Adoption and Awareness: The advantages and significance of employing medical imaging phantoms are not well known in some areas, particularly in developing nations. Healthcare providers might not prioritise purchasing phantoms for imaging calibration and validation as a result, which could result in lower adoption rates.

Technical Complexity and Maintenance: In order to achieve precise and useful results, using phantoms may require a high level of technical competence. Furthermore, these phantoms can be difficult and time-consuming to maintain and calibrate, which presents problems for institutions with little technical staff or funding.

Regulatory and Compliance Difficulties: Although phantom use is encouraged by rules, negotiating these regulations can be difficult and time-consuming. Manufacturing companies and users of medical imaging phantoms may find it difficult to ensure compliance with various regulatory standards in various geographical areas.

Limited Lifespan and Replacement Needs: Over time, material degradation or wear and tear can cause medical imaging phantoms to lose their usefulness. Regular replacement may be necessary, raising overall expenses and placing a financial strain on medical facilities and research institutes.

Alternative Techniques and Technologies: Computer simulations and other digital tools are examples of alternative techniques and technologies that can be used for imaging system calibration and validation. The demand for conventional phantom products may decline if consumers choose these substitutes for tangible phantoms in certain situations.

Financial Restraints: Investments in medical imaging phantoms and other innovative technologies may be impacted by financial restraints and downturns in the healthcare industry. Financial strains and budget shortages may force medical facilities to put other priorities ahead of buying and maintaining phantoms.

Lack of Standardisation: Variability in performance and quality might result from the absence of global guidelines for the creation and application of medical imaging phantoms. This lack of standardisation can make it difficult to compare data across many studies and institutions and impede the general adoption of phantoms.

Advanced Imaging Technologies Are Adopted Slowly in Certain Areas: There is also less of a need for matching phantoms in areas where the uptake of cutting-edge imaging technologies is sluggish. This may be the result of obstacles relating to education, infrastructure, or the economy that keep advanced imaging modalities from being widely used.

Environmental and Material Constraints: Certain materials may be subject to supply chain or environmental restrictions during the manufacturing of medical imaging phantoms. The cost, availability, and environmental effects of these materials can all have an impact on phantom manufacturing and cost.

Global Medical Imaging Phantoms Market Segmentation Analysis

The Global Medical Imaging Phantoms Market is Segmented on the basis of Product Type, Material, End-User, And Geography.

Medical Imaging Phantoms Market, By Product Type

• X-ray Phantoms
• MRI Phantoms
• Nuclear Imaging Phantoms
• Ultrasound Phantoms
• CT Phantoms

Based on Product Type, The market is segmented into X-ray Phantoms, MRI Phantoms, Nuclear Imaging Phantoms, Ultrasound Phantoms, CT Phantoms, and Others. The X-ray phantoms segment accounts for the highest revenue share of the Global Medical Imaging Phantoms Market in 2020 and is expected to dominate the market over the forecast period owing to their wide applications in medical imaging procedures, including radiography, mammography, and angiography. The increasing adoption of new X-ray machines and imaging device applications and initiatives taken by the government and non-profit organizations to create awareness of the available imaging techniques are expected to drive demand for X-ray phantoms over the forecast period.

Medical Imaging Phantoms Market, By Material

• Stimulating Devices
• False Organs

Based on Material, The market is segmented into Stimulating Devices, False Organs. The stimulating devices segment is expected to hold the largest revenue share of the Global Medical Imaging Phantoms Market during the forecast period owing to the increasing usage and growing adoption of the stimulating devices for brain, lung, and cancer diagnoses have further driven the market growth of this segment.

Global Medical Imaging Phantoms Market, By End-User

• Hospitals
• Diagnostic and Reference Laboratories
• Academic and Research Institutes
• Medical Device Companies

Based on End -User, The market is bifurcated into Hospitals, Diagnostic and Reference Laboratories, Academic and Research Institutes, Medical Device Companies and Others. The hospitals segment is expected to grow at the highest CAGR during the forecast period owing to the increasing number of patients suffering from various chronic disorders along with lifestyle diseases, and raising public awareness about these disorders. Additionally, well-established healthcare infrastructure, availability of various diagnostics and treatment facilities, higher purchasing power, and the presence of highly skilled healthcare professionals are driving the growth of the Market in the hospital's segment.

Medical Imaging Phantoms Market, By Geography

• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• Latin America
• On the basis of Geography, The Global Medical Imaging Phantoms Market is classified into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America. Among the regional markets, North America accounts for the largest revenue share in Global Medical Imaging Phantoms Market in 2020 and is expected to retain its dominance throughout the forecast period. The revenue growth in the North American market is mainly attributed to the increased investment in R&D activities for the development of technologically advanced medical devices for the diagnosis of various chronic disorders along with lifestyle diseases.
• Additionally, the increasing geriatric population, rising incidence and prevalence of various chronic disorders, rising healthcare sectors, presence of skilled professionals, and wide availability of technologically advanced Medical Imaging Phantoms are the major factors that boost in the region. The market in the Asia Pacific is projected to witness expansion at a significant growth rate during the forecast period, owing to the increasing focus on the development of healthcare infrastructure and the rising prevalence of various chronic disorders such as COPD and Chronic Kidney Disease (CKD) along with lifestyle diseases in the developing nations such as China, and India in this region.

Key Players

The "Global Medical Imaging Phantoms Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as Biodex Medical Systems, Inc., Gold Standard Phantoms, PTW Freiburg GmbH, Carville Limited., Computerized Imaging Reference Systems, Inc., Pure Imaging Phantoms, Dielectric Corporation, Kyoto Kagaku Co., Ltd., Modus Medical Devices Inc., PhantomX, among others.The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL MEDICAL IMAGING PHANTOMS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL MEDICAL IMAGING PHANTOMS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL MEDICAL IMAGING PHANTOMS MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 X-ray Phantoms
• 5.3 MRI Phantoms
• 5.4 Nuclear Imaging Phantoms
• 5.5 Ultrasound Phantoms
• 5.6 CT Phantoms
• 5.7 Others

6 GLOBAL MEDICAL IMAGING PHANTOMS MARKET, BY MATERIAL

• 6.1 Overview
• 6.2 Stimulating Devices
• 6.3 False Organs

7 GLOBAL MEDICAL IMAGING PHANTOMS MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Diagnostic and Reference Laboratories
• 7.4 Academic and Research Institutes
• 7.5 Medical Device Companies
• 7.6 Others

8 GLOBAL MEDICAL IMAGING PHANTOMS MARKET: GEOGRAPHICAL ANALYSIS

• 8.1 Overview
• 8.2 North America
  • 8.2.1 The U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 The U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL MEDICAL IMAGING PHANTOMS MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Biodex Medical Systems, Inc.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Gold Standard Phantoms
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 PTW Freiburg GmbH
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Carville Limited.
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Computerized Imaging Reference Systems, Inc.
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Pure Imaging Phantoms
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Development
• 10.7 Dielectric Corporation
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Kyoto Kagaku Co., Ltd.
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Modus Medical Devices Inc.
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 PhantomX
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1.1 Related Reports